Wu‐Chou Su
National Cheng Kung University Hospital(TW)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Cancer Immunotherapy and Biomarkers, Colorectal Cancer Treatments and Studies, Lung Cancer Diagnosis and Treatment
Most-Cited Works
- → Osimertinib in Untreated EGFR -Mutated Advanced Non–Small-Cell Lung Cancer(2017)5,101 cited
- → Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations(2013)3,181 cited
- → AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer(2015)2,095 cited
- → Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials(2015)1,573 cited
- → Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial(2012)952 cited
- → Cell Growth Arrest and Induction of Cyclin-Dependent Kinase Inhibitor p21 WAF1/CIP1 Mediated by STAT1(1996)804 cited